Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:CBSCOTCMKTS:IGXTNASDAQ:PYPDNASDAQ:ZCMD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCBSCCB Scientific$0.04-4.2%$0.04$0.02▼$0.15$7.05M1.1965,581 shs12,000 shsIGXTIntelGenx Technologies$0.17$0.17$0.09▼$0.22$29.17M2.47N/AN/APYPDPolyPid$3.19+8.1%$2.70$2.30▼$4.50$32.51M1.2517,933 shs44,597 shsZCMDZhongchao$1.13-5.5%$1.21$0.95▼$2.97$28.37M-0.03320,325 shs3,579 shs20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCBSCCB Scientific-4.22%-14.14%+28.27%-13.80%-38.43%IGXTIntelGenx Technologies0.00%0.00%0.00%0.00%0.00%PYPDPolyPid+3.87%+6.15%+5.73%+1.37%-34.44%ZCMDZhongchao+2.59%+3.48%+10.19%-1.24%-4.79%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCBSCCB ScientificN/AN/AN/AN/AN/AN/AN/AN/AIGXTIntelGenx TechnologiesN/AN/AN/AN/AN/AN/AN/AN/APYPDPolyPid2.1876 of 5 stars3.63.00.00.01.91.70.0ZCMDZhongchao1.1255 of 5 stars0.03.00.00.03.31.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCBSCCB Scientific 0.00N/AN/AN/AIGXTIntelGenx Technologies 0.00N/AN/AN/APYPDPolyPid 3.25Buy$11.33255.28% UpsideZCMDZhongchao 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest CBSC, ZCMD, IGXT, and PYPD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/2/2025PYPDPolyPidHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeBuy$11.004/14/2025PYPDPolyPidHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$11.00 ➝ $11.00(Data available from 6/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCBSCCB Scientific$140K50.39N/AN/AN/A∞IGXTIntelGenx Technologies$1.04M28.05N/AN/A($0.07) per share-2.39PYPDPolyPidN/AN/AN/AN/A$0.75 per shareN/AZCMDZhongchao$15.86M1.79N/AN/A$10.24 per share0.11Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCBSCCB ScientificN/AN/A0.00∞N/AN/AN/AN/AN/AIGXTIntelGenx Technologies-$9.93M-$0.06N/A∞N/AN/AN/AN/AN/APYPDPolyPid-$29.02M-$4.30N/A∞N/AN/A-624.10%-129.28%8/13/2025 (Estimated)ZCMDZhongchao-$11.34MN/A0.00∞N/AN/AN/AN/AN/ALatest CBSC, ZCMD, IGXT, and PYPD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025PYPDPolyPid-$0.80-$0.70+$0.10-$0.70N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCBSCCB ScientificN/AN/AN/AN/AN/AIGXTIntelGenx TechnologiesN/AN/AN/AN/AN/APYPDPolyPidN/AN/AN/AN/AN/AZCMDZhongchaoN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCBSCCB ScientificN/AN/AN/AIGXTIntelGenx TechnologiesN/AN/AN/APYPDPolyPid0.081.311.00ZCMDZhongchaoN/A6.055.94Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCBSCCB ScientificN/AIGXTIntelGenx TechnologiesN/APYPDPolyPid26.47%ZCMDZhongchao1.67%Insider OwnershipCompanyInsider OwnershipCBSCCB ScientificN/AIGXTIntelGenx Technologies42.05%PYPDPolyPid24.70%ZCMDZhongchao28.63%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCBSCCB Scientific5163.67 millionN/ANot OptionableIGXTIntelGenx Technologies38174.66 million101.21 millionNot OptionablePYPDPolyPid8010.19 million7.67 millionNo DataZCMDZhongchao14025.22 million18.00 millionNot OptionableCBSC, ZCMD, IGXT, and PYPD HeadlinesRecent News About These CompaniesWe're Keeping An Eye On Zhongchao's (NASDAQ:ZCMD) Cash Burn RateApril 27, 2025 | finance.yahoo.comZhongchao Inc. Expands Equity Base Through Private Placement and Warrant ExerciseDecember 13, 2024 | tipranks.comZhongchao Inc. Reports Mixed Financial Results for 2024November 2, 2024 | markets.businessinsider.comWhat's Going On With Zhongchao Stock Today?September 30, 2024 | msn.comWhy Is Scorpius (SCPX) Stock Down 79% Today?August 7, 2024 | msn.comWhy Is Zhongchao (ZCMD) Stock Up 52% Today?August 7, 2024 | investorplace.comZhongchao Inc. (ZCMD)July 19, 2024 | finance.yahoo.comZhongchao Full Year 2023 Earnings: US$4.35 loss per share (vs US$1.13 loss in FY 2022)May 3, 2024 | finance.yahoo.comWhy Is Zhongchao (ZCMD) Stock Up 103% Today?April 19, 2024 | investorplace.comZHONGCHAO Inc Ordinary Shares - Class AApril 16, 2024 | morningstar.comAltice USA, Genfit, Brooge Energy among premarket losers' packApril 5, 2024 | msn.comWhy Is Zhongchao (ZCMD) Stock Up 40% Today?April 4, 2024 | investorplace.comZhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of MedicationsMarch 12, 2024 | prnewswire.comWhy Paymentus Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving PremarketMarch 5, 2024 | msn.comWhy Is Zhongchao (ZCMD) Stock Up 15% Today?March 5, 2024 | investorplace.comZhongchao Inc. Announces 1-for-10 Share ConsolidationFebruary 27, 2024 | prnewswire.comZhongchao First Half 2023 Earnings: US$0.18 loss per share (vs US$0.004 profit in 1H 2022)December 28, 2023 | finance.yahoo.comZhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer TreatmentsDecember 11, 2023 | finance.yahoo.comZhongchao Inc. Launches Breast Cancer Follow-up Visit and Health Management Patient Guide Program on Breast Cancer Awareness DayOctober 23, 2023 | finance.yahoo.comZhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer PatientsSeptember 25, 2023 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCBSC, ZCMD, IGXT, and PYPD Company DescriptionsCB Scientific OTCMKTS:CBSC$0.04 0.00 (-4.22%) As of 06/2/2025 03:54 PM EasternCB Scientific, Inc., through its US and international subsidiaries, provides innovative products and services in the ambulatory non-invasive cardiac monitoring space. Our FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians.IntelGenx Technologies OTCMKTS:IGXT$0.17 0.00 (0.00%) As of 05/27/2025IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 and INT0055/2021 are for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunction; INT0043/2015, an oral film containing montelukast for treatment of Alzheimer and Parkinsons; INT0027/2011 to treat opioid addition; INT0010/2006 for treatment of neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, an oral film product for schizophrenia or bipolar 1 disorder; and INT0048/2020 for animal health. It is also develops INT0039/2013 for pain; and INT0053/2020 for the treatment of resistant depression. The company has licensing, development, and supply agreement with Tilray, Inc.; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.PolyPid NASDAQ:PYPD$3.19 +0.24 (+8.14%) As of 12:29 PM EasternPolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. It is also developing OncoPLEX, for the treatment of intra-tumoral cancer. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.Zhongchao NASDAQ:ZCMD$1.12 -0.07 (-5.46%) As of 10:03 AM EasternZhongchao Inc. provides healthcare information, education, and training services in the People's Republic of China. The company offers online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes of popular medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content. It also provides customized medical courses and medical training services; and patient management services through online platform under the Zhongxun brand. The company operates through its mdmooc.org online platform under the MDMOOC brand; and Sunshine Health Forums, a Wechat subscription account and mobile app. It serves enterprises, non-for-profit organizations, and medical journals, as well as healthcare professionals, nurses, doctors, and other healthcare workers. The company was founded in 2012 and is headquartered in Shanghai, China. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Steel Dynamics Shares Climb After Tariff Announcement Why Super Micro Computer's Upside Could Trigger a Short Squeeze Zscaler Will Hit $360 Soon: Here’s the How and Why Buy The Dip in Okta, There’s Nothing Wrong With the Outlook Ulta’s Beautiful Q1 Earnings Report Points to More Gains Ahead Why SoundHound Could Be a Short Squeeze in the Making Why Schwab US Dividend Equity ETF Could Lead the Rotation Chewy Stock Gets a New $7.1 Billion Investor and Analyst Upgrade Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
